E. Dailly

Professor E. Dailly serves as a Professor and Hospital Practitioner with research centered on antimicrobial resistance and clinical pharmacology. His work is institutionally associated with departments including Medical Mycology and Parasitology, Medicinal Chemistry, and Bacterial Resistances, though specific university affiliation remains unconfirmed in the source material.

His primary research domains encompass:

• Antimicrobial Resistance mechanisms and interventions
• Pharmacokinetics/pharmacodynamics optimization
• Clinical management of infectious diseases
• Gut microbiota interactions with therapeutics
• Antibiotic dosing strategies for complex infections

Recent publications demonstrate consistent focus on translational applications, particularly regarding gut microbiome modulation in multidrug-resistant infections and precision dosing nomograms for antibiotics like cloxacillin and amikacin. His clinical studies frequently address hospital-acquired infections and critically ill populations, emphasizing practical quality improvement in antimicrobial therapy.

Collaborative networks include extensive co-authorship with researchers across French medical institutions, reflecting integration within national infectious disease research consortia. The absence of specific grant leadership mentions suggests primarily collaborative project involvement rather than principal investigator roles.

His institutional context aligns with research themes including One Health approaches, microbiota-immunity interactions, and novel therapeutic target development, indicating participation in broader strategic initiatives beyond individual publications.